Aclarion, Inc. (ACONW)

US — Healthcare Sector
Peers: ACON  IVDAW  DRMAW  BEATW  EDBLW 

Automate Your Wheel Strategy on ACONW

With Tiblio's Option Bot, you can configure your own wheel strategy including ACONW - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol ACONW
  • Rev/Share 0.2489
  • Book/Share 71.9375
  • PB 0.0998
  • Debt/Equity 0.0
  • CurrentRatio 21.6833
  • ROIC -0.3631

 

  • MktCap 4181424.0
  • FreeCF/Share -26.4495
  • PFCF -0.7207
  • PE -0.2375
  • Debt/Assets 0.0
  • DivYield 0
  • ROE -1.269

 

  • Rating C
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 5
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

About Aclarion, Inc. (ACONW)

  • IPO Date
  • Website https://www.aclarion.com
  • Industry Medical - Healthcare Information Services
  • CEO Brent Ness
  • Employees 5
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.